Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration

JAMA Network Open Conversations
26/11/2019 10 min
Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration

Listen "Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration"

Descargar episodio Ver en sitio original

Episode Synopsis

Mary T. Bessesen, MD joins JAMA Network editors to discuss a cohort study that compares amputation and mortality rates among patients treated in the Veterans Health Administration for diabetic foot osteomyelitis with and without rifampin. Read the article here: https://ja.ma/37IBIT8. JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

More episodes of the podcast JAMA Network Open Conversations

Algorithm-Based Palliative Care in Patients With Cancer 21/02/2025
Geriatrics-Focused vs Traditional Primary Care in the Veterans Affairs Health Care System 16/01/2025
β-Lactam and Patients With MSSA Infective Endocarditis 20/12/2024
COVID-19 Incidence and Age Eligibility for Elementary School 14/11/2024
Exposure to Maternal COVID-19 and Offspring Neurodevelopment Through Age 24 Months 16/10/2024
A Continuing Education Intervention for Well-Being Among Health Care Workers 19/09/2024
State COVID-19 Vaccine Mandates and Uptake Among Health Care Workers in the US 14/08/2024
Large Language Model–Based Responses to Patients' In-Basket Messages 16/07/2024
The Privilege of Being Editor-in-Chief 24/06/2024
Preterm and Early-Term Delivery After Heat Waves 24/05/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA